Filed: 11/14/2024ACC: 0000899140-24-001252
📋 What this filing means
SARISSA CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 10 equity positions with a total reported market value of $402.33M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
10
Positions
$402.33M
Total AUM (reported)
51.66M
Total Shares
Allocation by class
COM$260.61M64.8%
COM CL A$67.53M16.8%
COM NEW$58.61M14.6%
SPONS ADR NEW$15.58M3.9%
Portfolio Concentration
Top 3$272.04M67.6%
4–10$130.28M32.4%
Top 3 weight
67.6%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 51.66M
Sole
Full voting authority
51.66M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole10
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings10
Rows:
INNOVIVA INC
SOLEShares7.28M
TypeSH
Market value$140.52M
34.93%
Sole
7.28M
Shared
0.00
None
0.00
IRONWOOD PHARMACEUTICALS INC
SOLEShares16.39M
TypeSH
Market value$67.53M
16.78%
Sole
16.39M
Shared
0.00
None
0.00
GILEAD SCIENCES INC
SOLEShares763.33K
TypeSH
Market value$64.00M
15.91%
Sole
763.33K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares1.11M
TypeSH
Market value$58.61M
14.57%
Sole
1.11M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares410.48K
TypeSH
Market value$47.30M
11.76%
Sole
410.48K
Shared
0.00
None
0.00
AMARIN CORP PLC
SOLEShares24.85M
TypeSH
Market value$15.58M
3.87%
Sole
24.85M
Shared
0.00
None
0.00
BIOGEN INC
SOLEShares26.95K
TypeSH
Market value$5.22M
1.30%
Sole
26.95K
Shared
0.00
None
0.00
LANTHEUS HLDGS INC
SOLEShares26K
TypeSH
Market value$2.85M
0.71%
Sole
26K
Shared
0.00
None
0.00
VOR BIOPHARMA INC
SOLEShares618K
TypeSH
Market value$432.6K
0.11%
Sole
618K
Shared
0.00
None
0.00
REGULUS THERAPEUTICS INC
SOLEShares185.18K
TypeSH
Market value$290.7K
0.07%
Sole
185.18K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
INNOVIVA INCSOLE | COM | 7.28M | SH | $140.52M 34.93% | 7.28M | 0.00 | 0.00 |
IRONWOOD PHARMACEUTICALS INCSOLE | COM CL A | 16.39M | SH | $67.53M 16.78% | 16.39M | 0.00 | 0.00 |
GILEAD SCIENCES INCSOLE | COM | 763.33K | SH | $64.00M 15.91% | 763.33K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 1.11M | SH | $58.61M 14.57% | 1.11M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 410.48K | SH | $47.30M 11.76% | 410.48K | 0.00 | 0.00 |
AMARIN CORP PLCSOLE | SPONS ADR NEW | 24.85M | SH | $15.58M 3.87% | 24.85M | 0.00 | 0.00 |
BIOGEN INCSOLE | COM | 26.95K | SH | $5.22M 1.30% | 26.95K | 0.00 | 0.00 |
LANTHEUS HLDGS INCSOLE | COM | 26K | SH | $2.85M 0.71% | 26K | 0.00 | 0.00 |
VOR BIOPHARMA INCSOLE | COM | 618K | SH | $432.6K 0.11% | 618K | 0.00 | 0.00 |
REGULUS THERAPEUTICS INCSOLE | COM | 185.18K | SH | $290.7K 0.07% | 185.18K | 0.00 | 0.00 |